Mie Nishio

Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409

Yasuhiro Kita, Yoshimi Hirasawa, Kazuhiro Maeda et al. · European Journal of Pharmacology · 1994 · 112 citations

Molecular Pharmacology, Release Accounts, Potent Pharmacological Actions +11

Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig

Yasuko Kato, Yasuhiro Kita, Yoshimi Hirasawa-Taniyama et al. · European Journal of Pharmacology · 2003 · 94 citations

Inflammation, Thrombosis, Thrombopoiesis +13

FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty

Jiro Seki, Mie Nishio, Yasuko Kato et al. · Atherosclerosis · 1995 · 65 citations

Molecular Physiology, Angiogenesis, Smooth Muscle Proliferation +10

In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist

Yasuko Kato, Yasuhiro Kita, Mie Nishio et al. · European Journal of Pharmacology · 1999 · 56 citations

Thrombopoiesis, Thrombosis, Blood Platelet +11

Comparison of antiplatelet effects of FK409, a spontaneous nitric oxide releaser, with those of TRK-100, a prostacyclin analogue

Yoshimi Hirasawa, Mie Nishio, Kazuhiro Maeda et al. · European Journal of Pharmacology · 1995 · 16 citations

Medicinal Chemistry, Biochemistry, Medicine +7